Tyk2 mutation homologous to V617F Jak2 is not found in essential thrombocythaemia, although it induces constitutive signaling and growth factor independence

Kotaro Shide, Kazuya Shimoda, Kenjiro Kamezaki, Haruko Kakumitsu, Takashi Kumano, Akihiko Numata, Fumihiko Ishikawa, Katsuto Takenaka, Ken Yamamoto, Tadashi Matsuda, Mine Harada

研究成果: ジャーナルへの寄稿 › 記事

5 引用 (Scopus)

抄録

A single somatic mutation, V617F, in the pseudokinase domain of the Jak2 is the primary cause of many chronic myeloproliferative diseases. As valine 617 of Jak2 is conserved as valine 678 of Tyk2, we examined the effect of a homologous mutation in Tyk2 (V678F Tyk2) on cell growth. V678F Tyk2 augmented the transcriptional activity of Stat3 and Stat5. The expression of V678F Tyk2 in Ba/F3 cells induced autonomous cell growth and showed hyper-responsiveness to IL-3. Although V678F Tyk2 might cause MPD, no cases of ET patients lacking the V617F Jak2 mutation harbored the Tyk2 mutation.

元の言語英語
ページ（範囲）1085-1092
ページ数8
ジャーナルLeukemia Research
巻31
発行部数8
DOI
出版物ステータス出版済み - 8 1 2007

Fingerprint

Essential Thrombocythemia
Intercellular Signaling Peptides and Proteins
Mutation
Valine
Interleukin-3
Growth
Chronic Disease

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Cancer Research

これを引用

Tyk2 mutation homologous to V617F Jak2 is not found in essential thrombocythaemia, although it induces constitutive signaling and growth factor independence. / Shide, Kotaro; Shimoda, Kazuya; Kamezaki, Kenjiro; Kakumitsu, Haruko; Kumano, Takashi; Numata, Akihiko; Ishikawa, Fumihiko; Takenaka, Katsuto; Yamamoto, Ken; Matsuda, Tadashi; Harada, Mine.

：: Leukemia Research, 巻 31, 番号 8, 01.08.2007, p. 1085-1092.

研究成果: ジャーナルへの寄稿 › 記事

Shide, K, Shimoda, K, Kamezaki, K, Kakumitsu, H, Kumano, T, Numata, A, Ishikawa, F, Takenaka, K, Yamamoto, K, Matsuda, T & Harada, M 2007, 'Tyk2 mutation homologous to V617F Jak2 is not found in essential thrombocythaemia, although it induces constitutive signaling and growth factor independence', Leukemia Research, 巻. 31, 番号 8, pp. 1085-1092. https://doi.org/10.1016/j.leukres.2006.11.003
Shide K, Shimoda K, Kamezaki K, Kakumitsu H, Kumano T, Numata A その他. Tyk2 mutation homologous to V617F Jak2 is not found in essential thrombocythaemia, although it induces constitutive signaling and growth factor independence. Leukemia Research. 2007 8 1;31(8):1085-1092. https://doi.org/10.1016/j.leukres.2006.11.003
Shide, Kotaro ; Shimoda, Kazuya ; Kamezaki, Kenjiro ; Kakumitsu, Haruko ; Kumano, Takashi ; Numata, Akihiko ; Ishikawa, Fumihiko ; Takenaka, Katsuto ; Yamamoto, Ken ; Matsuda, Tadashi ; Harada, Mine. / Tyk2 mutation homologous to V617F Jak2 is not found in essential thrombocythaemia, although it induces constitutive signaling and growth factor independence. ：: Leukemia Research. 2007 ; 巻 31, 番号 8. pp. 1085-1092.
@article{e07e316dc5014318a3ffbf72e5a7e041,
title = "Tyk2 mutation homologous to V617F Jak2 is not found in essential thrombocythaemia, although it induces constitutive signaling and growth factor independence",
abstract = "A single somatic mutation, V617F, in the pseudokinase domain of the Jak2 is the primary cause of many chronic myeloproliferative diseases. As valine 617 of Jak2 is conserved as valine 678 of Tyk2, we examined the effect of a homologous mutation in Tyk2 (V678F Tyk2) on cell growth. V678F Tyk2 augmented the transcriptional activity of Stat3 and Stat5. The expression of V678F Tyk2 in Ba/F3 cells induced autonomous cell growth and showed hyper-responsiveness to IL-3. Although V678F Tyk2 might cause MPD, no cases of ET patients lacking the V617F Jak2 mutation harbored the Tyk2 mutation.",
author = "Kotaro Shide and Kazuya Shimoda and Kenjiro Kamezaki and Haruko Kakumitsu and Takashi Kumano and Akihiko Numata and Fumihiko Ishikawa and Katsuto Takenaka and Ken Yamamoto and Tadashi Matsuda and Mine Harada",
year = "2007",
month = "8",
day = "1",
doi = "10.1016/j.leukres.2006.11.003",
language = "English",
volume = "31",
pages = "1085--1092",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "8",

}

TY - JOUR

T1 - Tyk2 mutation homologous to V617F Jak2 is not found in essential thrombocythaemia, although it induces constitutive signaling and growth factor independence

AU - Shide, Kotaro

AU - Shimoda, Kazuya

AU - Kamezaki, Kenjiro

AU - Kakumitsu, Haruko

AU - Kumano, Takashi

AU - Numata, Akihiko

AU - Ishikawa, Fumihiko

AU - Takenaka, Katsuto

AU - Yamamoto, Ken

AU - Matsuda, Tadashi

AU - Harada, Mine

PY - 2007/8/1

Y1 - 2007/8/1

N2 - A single somatic mutation, V617F, in the pseudokinase domain of the Jak2 is the primary cause of many chronic myeloproliferative diseases. As valine 617 of Jak2 is conserved as valine 678 of Tyk2, we examined the effect of a homologous mutation in Tyk2 (V678F Tyk2) on cell growth. V678F Tyk2 augmented the transcriptional activity of Stat3 and Stat5. The expression of V678F Tyk2 in Ba/F3 cells induced autonomous cell growth and showed hyper-responsiveness to IL-3. Although V678F Tyk2 might cause MPD, no cases of ET patients lacking the V617F Jak2 mutation harbored the Tyk2 mutation.

AB - A single somatic mutation, V617F, in the pseudokinase domain of the Jak2 is the primary cause of many chronic myeloproliferative diseases. As valine 617 of Jak2 is conserved as valine 678 of Tyk2, we examined the effect of a homologous mutation in Tyk2 (V678F Tyk2) on cell growth. V678F Tyk2 augmented the transcriptional activity of Stat3 and Stat5. The expression of V678F Tyk2 in Ba/F3 cells induced autonomous cell growth and showed hyper-responsiveness to IL-3. Although V678F Tyk2 might cause MPD, no cases of ET patients lacking the V617F Jak2 mutation harbored the Tyk2 mutation.

UR - http://www.scopus.com/inward/record.url?scp=34249949735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249949735&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2006.11.003

DO - 10.1016/j.leukres.2006.11.003

M3 - Article

VL - 31

SP - 1085

EP - 1092

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 8

ER -

文献にアクセス